The field of myeloma and chronic lymphocytic leukemia is changing at pace. Due to significant advances in technology, particularly in genomics, our understanding of normal and neoplastic haemopoiesis is constantly improving. However, the real challenge is how these technological advances and genomic information can be transferred from the laboratory to the clinical management of the individual patient. The study day will focus on the recent advances seen within myeloma, chronic lymphocytic leukemia and myeloproliferations and how diagnostic advances guide the individual patient pathway.

This event was postponed from 26 June.

Update 24/11/2020- This event was to happen 27th November 2020 and has been postponed for a second time to 25th June 2021

Programme- to be updated 2021